Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

ZITHROMAX Drug Profile

« Back to Dashboard

What is the patent landscape for Zithromax, and what generic alternatives are available?

Zithromax is a drug marketed by Pfizer and is included in seven NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has sixty-eight patent family members in forty-two countries.

The generic ingredient in ZITHROMAX is azithromycin. There are thirty-one drug master file entries for this compound. Fifty-five suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the azithromycin profile page.

Summary for Tradename: ZITHROMAX

Suppliers / Packagers: see list13
Bulk Api Vendors: see list33
Clinical Trials: see list18
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZITHROMAX at DailyMed

Pharmacology for Tradename: ZITHROMAX

Drug ClassMacrolide Antimicrobial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
FOR SUSPENSION;ORAL050710-001Oct 19, 1995ABRXYesNo6,268,489► SubscribeY ► Subscribe
TABLET;ORAL050784-001May 24, 2002ABRXNoNo6,268,489► SubscribeY ► Subscribe
TABLET;ORAL050730-001Jun 12, 1996ABRXYesYes6,268,489► SubscribeY ► Subscribe
FOR SUSPENSION;ORAL050693-001Sep 28, 1994RXYesYes6,268,489► SubscribeY ► Subscribe
FOR SUSPENSION;ORAL050710-002Oct 19, 1995ABRXYesYes6,268,489► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus